In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at ...
For years, pharmacy benefit managers have been the target of ire for ... That same month, the FTC published a report ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.
The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming ...
The federal government is suing three big pharmacy benefit managers (PBMs) over a system of drug rebates that regulators say ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...
The FTC accuses the largest pharmacy benefit manager companies of unfairly boosting prices on prescription drugs.
The Federal Trade Commission on Friday sued prescription-drug middlemen owned by CVS Health Corp., Cigna Group and UnitedHealth Group Inc., alleging that they artificially pumped up prices of insulin ...
The Federal Trade Commission alleges CVS Health’s Caremark Rx, Cigna’s Express Scripts and United Health Group’s OptumRx ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback